Dexmedetomidine Versus Ketamine Versus Midazolam in Endoscopic Procedures
NCT ID: NCT04597268
Last Updated: 2023-01-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
75 participants
INTERVENTIONAL
2020-11-01
2022-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy of Dexmedetomidine-Propofol Versus Ketamine-Propofol for Sedation
NCT06756594
Efficacy of Propofol Combination With Either Ketamine, Dexmedetomidine or Midazolam for Sedation During Upper Gastrointestinal Endoscopic Procedures
NCT07190612
Dexmedetomidine-ketamine Versus Propofol-ketamine for Sedation During Endoscopy in Hepatic Patients
NCT04906772
Propofol Versus Dexmedetomidine for Sedation of Cancer Patients Undergoing ERCP
NCT06409104
A Comparison of Efficacy and Safety During Endoscopic Submucosal Dissection Between Dexmedetomidine-remifentanil and Propofol-remifentanil
NCT01920113
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
dexmedetomidine
IV dexmedetomidine
Dexmedetomidine
intravenous dexmedetomidine 1 mic/kg
ketamine
IV ketamine
Ketamine
ketamine 1mg/kg
Midazolam
IV midazolam
Midazolam
midazolam 0.05 mg/kg
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Dexmedetomidine
intravenous dexmedetomidine 1 mic/kg
Ketamine
ketamine 1mg/kg
Midazolam
midazolam 0.05 mg/kg
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ≥ Age 18 years
* ASA I-II
Exclusion Criteria
* impaired renal or liver functions
* hypertensive patients
* patients with cardiovascular
* cerebrovascular disease
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Institute, Egypt
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Walaa Youssef Elsabeeny
Lecturer of anesthesia and pain management
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Walaa Y Elsabeeny, MD
Role: PRINCIPAL_INVESTIGATOR
Lecturer
Nahla Y Shehab, MD
Role: STUDY_DIRECTOR
Lecturer
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Walaa Y Elsabeeny
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AP2007-50110
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.